课题基金 / 基金详情

Identification of Mechanisms by which Insulin Receptor Substrates (IRS) Regulate Cardiomyocyte Metabolism and Survival

Identification of Mechanisms by which Insulin Receptor Substrates (IRS) Regulate Cardiomyocyte Metabolism and Survival
胰岛素受体底物 (IRS) 调节心肌细胞代谢和存活的机制的鉴定
批准号:
233893572
负责人:
Dr. Christian Riehle
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Fellowships
财政年份:
2013
资助国家:
德国
项目状态:
已结题
起止时间:
2012-12-31 至 2013-12-31

项目摘要

项目成果

Dr. Christian Riehle的其他基金

相似基金

相关文献

中文摘要
翻译
在2型糖尿病患者中进行严格代谢控制的临床试验,包括强化胰岛素治疗,增加了死亡率和主要心血管事件的数量。我们之前在一个压力过载模型中表明,高胰岛素血症本身激活了心脏中的胰岛素信号级联,从而加速了细胞死亡和心力衰竭。胰岛素和IGF-1信号是由胰岛素受体底物(IRS) 1和2介导的。我们的初步研究确定了irs -异构体对心脏代谢和生长的特异性贡献。在压力过载的情况下,irs1缺失具有有益的影响,而IRS2缺失则是有害的。这项建议将阐明其基本机制。此外,虽然心肌细胞特异性缺失IRS1或IRS2的小鼠存活正常,但两种IRS亚型的缺失导致心力衰竭死亡率增加。同样,心肌细胞特异性缺失胰岛素(IR)和IGF-1受体的小鼠死于心力衰竭。除了IR和IGF-1受体外,IRS蛋白还与细胞因子受体和整合素相连。因此,我们建议研究IR/IGF-1受体依赖性和独立机制,这些机制有助于irs1 /2缺陷心脏的心力衰竭。总之,这些研究将为压力过载条件下胰岛素信号的IRS亚型特异性调节提供新的见解,并剖析心肌细胞中由IRS1和IRS2转导的上游信号。
英文摘要
Clinical trials of tight metabolic control in subjects with type 2 diabetes, which involve intensive insulin therapy increased mortality and the number of major cardiovascular events. We have previously shown in a model of pressure overload that hyperinsulinemia per se activates the insulin signaling cascade in the heart and thereby accelerates cell death and heart failure. Insulin and IGF-1 signaling is mediated by insulin receptor substrates (IRS) 1 and 2. Our preliminary studies identified an IRS-isoform specific contribution to cardiac metabolism and growth. In the presence of pressure overload, IRS1-deletion had beneficial effects whereas absence of IRS2 was detrimental. The underlying mechanisms will to be elucidated in this proposal. Furthermore, while mice with cardiomyocyte-specific deletion of either IRS1 or IRS2 had normal survival, knockdown of both IRS isoforms resulted in increased mortality due to heart failure. Similarly, mice with a combined cardiomyocyte-specific deletion of both insulin (IR) and IGF-1 receptors died from heart failure. In addition to IR and IGF-1 receptors, IRS proteins are linked to cytokine receptors and integrins. Therefore, we propose to investigate IR/IGF-1 receptor dependent and independent mechanisms that contribute to heart failure in IRS1/2-deficient hearts. Together, these studies will provide new insight into the IRS isoform-specific modulation of insulin signaling under conditions of pressure overload and dissect the upstream signals that are transduced by IRS1 and IRS2 in cardiomyocytes.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1128/mcb.01109-14
发表时间: 2014-12
期刊: Molecular and Cellular Biology
影响因子: 5.3
作者: [A. Wende;Brian T. O’Neill;H. Bugger;C. Riehle;Joseph Tuinei;J. Buchanan;Kensuke Tsushima;Li Wang-]
通讯作者: A. Wende;Brian T. O’Neill;H. Bugger;C. Riehle;Joseph Tuinei;J. Buchanan;Kensuke Tsushima;Li Wang-
DOI: 10.1253/circj.cj-14-1080
发表时间: 2014
期刊: Circulation journal : official journal of the Japanese Circulation Society
影响因子: --
作者: [Riehle C, Abel ED]
通讯作者: Abel ED
Insulin Receptor Substrates Are Essential for the Bioenergetic and Hypertrophic Response of the Heart to Exercise Training
胰岛素受体底物对于心脏对运动训练的生物能和肥厚反应至关重要
DOI: 10.1128/mcb.00426-14
发表时间: 2014
期刊: Molecular and Cellular Biology
影响因子: 5.3
作者: [Riehle C, Wende AR, Oliveira KJ, Pereira RO, Jaishy BP, Bevins J, Valdez S, Kim BJ, Moreira AB, Weatherford ET, Manivel R, Rawlings TA, Rech M, White MF, Abel ED]
通讯作者: Abel ED
The Impact of Lrat on Cardiomyocyte Energetics and Survival
  • 批准号:
    414169410
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2018
  • 负责人:
    Dr. Christian Riehle
  • 依托单位:
The Impact of Rhot1 and 2 on Cardiomyocyte Energetics and Survival
国内基金
海外基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI Z
  • 依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
  • 批准号:
    W2433169
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI ZHANG
  • 依托单位: